Showing 2,387 news articles about HIV treatment

Filters Content type: Editors' picks Topic: HIV treatment

Treatment is recommended for all people living with HIV. It involves taking a combination of antiretroviral drugs. This stops the virus from replicating and allows the immune system to strengthen and fight infections.

Treatment guidelines

1.3m switched to new ARV, but weight gain is a concern

Editor's pick
Spotlight
25 August 2020
Weight gain & lipodystrophy

Diabetes drug metformin decreases weight in people with HIV

Editor's pick
Healio
19 August 2020
Bad science & bogus treatments

Gene Therapy Cure Claims Are Premature, Advocates Say

Editor's pick
POZ
17 August 2020
Access to healthcare

Obamacare's unexpected bonus: How the Affordable Care Act is helping middle-aged Americans during the pandemic

Editor's pick
The Conversation
4 August 2020
Pharmaceutical industry

Rival drugmakers' joint trial of medicines for COVID includes an experimental HIV drug

Editor's pick
Thomson Reuters Foundation
4 August 2020
Global health initiatives

Covidization of research: what are the risks?

Editor's pick
Nature
3 August 2020
New & experimental HIV treatments

What Are the New HIV Treatment and Prevention Drugs Under Development in 2020?

Editor's pick
TheBodyPro
28 July 2020
Adherence

Novel Immunoassay Demonstrates Predictive Utility in PrEP Adherence, HIV Protection

Editor's pick
Infectious Disease Advisor
28 July 2020
Pregnancy and vertical transmission

Obesity linked to dolutegravir, especially with TAF, could increase risk of adverse pregnancy outcomes

Editor's pick
HTB
21 July 2020
Pharmaceutical industry

U.K. marketing police slam Gilead for claiming Biktarvy tolerability beats GSK rival

Editor's pick
FiercePharma
15 July 2020
New & experimental HIV treatments

FDA spurns CytoDyn's HIV drug because of missing info

Editor's pick
FierceBiotech
14 July 2020
Pregnancy and vertical transmission

Dolutegravir With TAF or TDF Could Increase Adverse Pregnancy Outcomes

Editor's pick
NATAP
13 July 2020
New & experimental HIV treatments

Dewpoint Therapeutics Collaborates with Merck to Evaluate Novel Approach for the Treatment of HIV

Editor's pick
Dewpoint press release
13 July 2020
Neurological & cognitive problems

Neuropathy and Neuropathic Pain Still on Rise in HIV+, But No Clear Links to ART

Editor's pick
NATAP
10 July 2020
People who inject drugs

Event-Driven PrEP Patients Face Retention Issues in Thai Study

Editor's pick
Contagion Live
9 July 2020
Resistance

Doravirine Benefits HIV-1 Patients with Common Resistance Associated Mutations

Editor's pick
Contagion Live
8 July 2020
HIV treatment for children & young people

Combatting Virologic Failure in Children with HIV using Targeted Drug Resistance Testing

Editor's pick
Contagion Live
8 July 2020
Treatment simplification strategies

As Two-Drug HIV Treatment Rises, Long-Term Inflammation Becomes a Potential Concern

Editor's pick
TheBodyPro
8 July 2020
People with limited treatment options

Heavily Pretreated US HIV Patients Face Clinical Hurdles, Higher Death Risk

Editor's pick
NATAP
6 July 2020
Injectable & long-acting HIV treatment

ViiV Healthcare presents positive data from first-ever implementation research study on how best to integrate an investigational once-monthly injectable HIV treatment in US healthcare practices

Editor's pick
ViiV press release
4 July 2020
Injectable & long-acting HIV treatment

GSK says it is within weeks of resubmitting HIV injection Cabenuva

Editor's pick
Reuters
3 July 2020
New & experimental HIV treatments

ViiV Healthcare announces US FDA approval for Rukobia (fostemsavir), a first-in-class treatment for HIV in adults with few treatment options available

Editor's pick
ViiV press release
3 July 2020
New & experimental HIV treatments

Experimental HIV drug seems effective at a twice-a-year dose, study finds

Editor's pick
STAT
2 July 2020
Economic & social inequality

Undetectable to viral rebound: When and why?

Editor's pick
San Francisco AIDS Foundation
24 June 2020